Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease.

Date AA, Rais R, Babu T, Ortiz J, Kanvinde P, Thomas AG, Zimmermann SC, Gadiano AJ, Halpert G, Slusher BS, Ensign LM. Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease. J Control Release. 2017 Oct 10; 263:132-138.

View in: PubMed

subject areas

Animals
Colitis
Colon
Enema
Glutamate Carboxypeptidase II
Inflammatory Bowel Diseases
Intestinal Mucosa
Male
Mice, Inbred BALB C
Organophosphorus Compounds
Trinitrobenzenesulfonic Acid

authors with profiles

Abhijit Date, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support